Article Information
History
- May 11, 2020.
Article Versions
- You are currently viewing Version 1 of this article (May 11, 2020 - 05:06).
- Version 2 (July 3, 2021 - 22:54).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Jie Zheng1,†,*,
- Yuemiao Zhang2,†,*,
- Yi Liu1,
- Denis Baird1,
- Xingzi Liu2,
- Lin Wang3,
- Hong Zhang2,
- George Davey Smith1,4 and
- Tom R Gaunt1,4
- 1MRC Integrative Epidemiology Unit (IEU), Bristol Medical School, University of Bristol, Oakfield House, Oakfield Grove, Bristol, BS8 2BN, United Kingdom
- 2Renal Division, Peking University First Hospital, Peking University Institute of Nephrology, Key Laboratory of Renal Disease, Ministry of Health of China, Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education, Beijing, People’s Republic of China
- 3Department of Microbiology and Infectious Disease Centre, School of Basic Medical Sciences, Peking University Health Science Centre, Beijing, China
- 4NIHR Biomedical Research Centre at the University Hospitals Bristol NHS Foundation Trust and the University of Bristol, United Kingdom
- ↵*To whom correspondence should be addressed: Jie Zheng: jie.zheng{at}bristol.ac.uk, Yuemiao Zhang: zhangyuemiao{at}bjmu.edu.cn
↵† Equal contribution
Posted May 11, 2020.
Multi-omics study revealing tissue-dependent putative mechanisms of SARS-CoV-2 drug targets on viral infections and complex diseases
